General Archive
-
2023 sustainability report
Our sustainability policies and initiatives reflect our commitment to the uncompromising quality, integrity, inclusion and accountability that is required of…
-
Articles & blogsThe new LifeArc identity: More than just a fresh coat of paint
In the world of medical research, it’s vital that we keep challenging ourselves to push forwards. We’ve created a new…
-
Articles & blogsLifeArc Translational Science Summit: Highlights and key takeaways
The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…
-
News releasesDr Sam Barrell CBE appointed as CEO of LifeArc
LifeArc is pleased to announce the appointment of Dr Sam Barrell, CBE, as Chief Executive Officer. Sam’s appointment follows an…
-
News releasesTwo influential life science leaders join LifeArc science team
This quarter, we look forward to welcoming 2 new colleagues – Heather McKinnon and Giovanna Lalli – to strategic leadership…
-
News releases2023 wrapped: Our highlights from a successful year
As 2023 comes to a close, we reflect on another great year at LifeArc filled with, exciting partnerships and initiatives,…
-
News releasesLifeArc contributes to revitalisation of groundbreaking science education centre for children and young people
Centre of the Cell is the first informal science education centre in the world to be located within working biomedical…
-
News releasesLifeArc opens search for next CEO
For the past several years, LifeArc has been on a journey of transformative change. As we enter a pivotal time,…
-
News releases
Dr Melanie Lee CBE steps down as CEO of LifeArc
Dr. Melanie Lee has notified the Board of her decision to step down as Chief Executive Officer, effective 30 September…
-
Articles & blogs
2022 wrapped – our highlights from a pivotal year
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
-
Ventures funding, News releases
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has…
-
News releasesLifeArc bolsters scientific leadership by appointing new Chief Scientific Officer
Welcome to Dr Dave Powell, who has joined LifeArc as our first Chief Scientific Officer (CSO). Dave is an experienced scientist and leader, with exceptional translational…